Ducommun Incorporated 2014 Form 10-K Summary
Business context and reporting period
Ducommun provides engineering and manufacturing services for aerospace, defense, industrial, natural resources, medical and other high-reliability markets through Ducommun AeroStructures (DAS) and Ducommun LaBarge Technologies (DLT). The filing covers the fiscal year ended December 31, 2014, including fourth-quarter results. Aerospace and defense represented approximately 82% of 2014 revenue, with commercial aerospace at 33% and military and space at 49%.
The filing was signed April 9, 2015. It includes restated prior-period financial statements and quarterly information following the discovery of employee misconduct involving labor-cost allocations to a long-term contract and errors in income-tax and deferred-tax reconciliations.
Key financial metrics
| Metric | 2014 | 2013, as restated | Change |
|---|---|---|---|
| Net revenue | $742.0 million | $736.7 million | Up 0.7% |
| Gross profit | $140.3 million | $124.2 million | Up $16.2 million |
| Gross margin | 18.9% | 16.9% | Up 2.0 points |
| Operating income | $51.8 million | $39.3 million | Up $12.5 million |
| Net income | $19.9 million | $11.4 million | Up $8.5 million |
| Diluted EPS | $1.79 | $1.05 | Up $0.74 |
| Operating cash flow | $53.4 million | $46.0 million | Up $7.5 million |
| Adjusted EBITDA | $83.3 million | $77.2 million | Up $6.1 million |
| Adjusted EBITDA margin | 11.2% | 10.5% | Up 0.7 points |
Fourth-quarter 2014 revenue was $187.6 million and net income was $5.2 million, or $0.46 diluted EPS. Fourth-quarter 2013 included a $14.1 million charge related primarily to the Embraer Legacy 450/500 and Boeing 777 wing-tip contracts.
At December 31, 2014, cash and equivalents were $45.6 million, working capital was $217.7 million, total assets were $747.6 million and shareholders’ equity was $256.6 million. Total debt was $290.1 million, consisting primarily of $200.0 million of 9.75% senior unsecured notes and a $90.0 million senior secured term loan bearing interest at 4.75%. Unused revolving-credit capacity was approximately $58.5 million.
Material changes versus the prior comparable period
- Commercial aerospace revenue increased approximately 14%, while military and space revenue declined approximately 8%; non-aerospace and defense revenue increased approximately 7%.
- DAS revenue increased 1% to $320.0 million, and segment operating income increased to $34.9 million from $19.0 million, primarily because of the prior-year contract charges and a 2014 reversal of a forward-loss reserve following a customer settlement.
- DLT revenue was essentially flat at $422.1 million. Commercial aerospace and non-aerospace revenue increased, but defense technologies revenue declined approximately 7%; segment operating income decreased to $34.6 million from $37.0 million.
- Gross margin improved primarily because of the reversal of a forward-loss reserve, favorable product mix, a workers’ compensation audit refund and the absence of the prior-year contract charges.
- Interest expense decreased to $28.1 million from $29.9 million as debt balances declined and the term loan had been repriced.
- Backlog declined to $559.3 million from $620.0 million, primarily because of lower defense-technology and defense-structures backlog. Approximately $447.4 million was expected to be delivered in 2015.
- The company made $42.6 million of voluntary term-loan prepayments, reducing debt by approximately $42.7 million during the year.
Guidance, outlook, commentary and risks
- Management expected approximately $15.0 million of 2015 capital expenditures, funded by operating cash flow, primarily to support new contract awards.
- Management planned additional term-loan prepayments and expected to refinance the term loan in 2015, subject to market conditions. The term loan matures in 2017, the revolving facility in 2016 and the $200.0 million notes in 2018.
- Management cited strong commercial-aerospace build rates and continued growth opportunities from moving toward more complex Tier 2 assemblies, but noted continued defense weakness and customer pricing pressure.
- The company remained exposed to cyclical commercial aerospace, defense-budget reductions and sequestration, customer and program concentration, fixed-price contract overruns, supply-chain constraints, competition, regulatory compliance and international operations.
- Boeing represented 20% of 2014 revenue and Raytheon 9%; the top ten customers represented 59% of revenue. These concentrations increase sensitivity to customer production rates, cancellations and delays.
- Management and the auditors identified material weaknesses in internal control over financial reporting. The weaknesses involved the control environment, labor-hour reporting and contract-loss estimates, and income-tax accounting and disclosures. Disclosure controls and internal control over financial reporting were considered ineffective at December 31, 2014.
- The company had accrued approximately $1.5 million for groundwater contamination matters and approximately $0.4 million for a West Covina landfill matter. A separate environmental liability was preliminarily estimated at $0.4 million to $3.1 million.
- A False Claims Act lawsuit involving Boeing and Ducommun had been dismissed on summary judgment, but the relators appealed. The government had declined to intervene; the filing states that the potential claims alleged damages of up to $1.6 billion or, alternatively, $851 million.
- The company did not file the 10-K by March 31, 2015, resulting in defaults under its credit facilities and notes, but not events of default. The filing states that the defaults were cured upon filing.
Most important facts for investors to verify
- Read Note 2 to confirm the full quantitative effect of the restatement on prior earnings, equity, taxes, goodwill and contract-loss reserves.
- Assess whether the remediation plan eliminates the four material weaknesses and whether future filings report effective controls.
- Verify the company’s ability to refinance or repay the 2017 term loan and 2018 notes while maintaining covenant compliance.
- Monitor backlog conversion, defense-program reductions and commercial-aerospace production rates, particularly given the backlog decline.
- Evaluate exposure to Boeing, Raytheon and the broader top-ten-customer concentration.
- Review developments in the False Claims Act appeal, environmental remediation and any further regulatory or litigation consequences arising from the restatement and employee misconduct.